№ files_lp_4_process_2_49132
File format: docx Character count: 2395 File size: 28 KB
This document is a scientific article presenting experimental results on tumor-bearing mice treated with MVA-MUC1 and ODN1826, with a focus on tumor-infiltrating lymphocytes and inflammatory gene expression.
Year: Not specified
Region / city: Not specified
Topic: Tumor immunology, treatment methods
Document type: Scientific article
Organization / institution: Not specified
Author: Not specified
Target audience: Researchers, Immunologists
Period of validity: Not specified
Approval date: Not specified
Date of changes: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Continuing Education/Continuing Medical Education (CE/CME): An Introduction to TIL (Tumor-Infiltrating Lymphocyte) Therapy in Metastatic Melanoma — October 30, 2025
Year: 2025
Date: October 30, 2025
Time: 5:00 PM
Field: Oncology; Surgery
Topic: Tumor-Infiltrating Lymphocyte (TIL) Therapy; Metastatic Melanoma
Document Type: Continuing Education / Continuing Medical Education Activity Description
Organizing Institution: Ascension
Accrediting Bodies: Accreditation Council for Continuing Medical Education; Accreditation Council for Pharmacy Education; American Nurses Credentialing Center
Credit Designation: 1.50 IPCE credits; 1.50 ANCC contact hours
Target Audience: Interdisciplinary healthcare team; Oncology and Surgery specialties
Faculty: Jatandra Birney, PharmD, BCOP
Activity Coordinator: Tari Hopper, BSN
Commercial Support: None
Conflict of Interest Disclosure: No relevant financial relationships disclosed
Topics: MVA-MUC1 ODN1826 Tumor-Infiltrating